ADD ANYTHING HERE OR JUST REMOVE IT…
Wrong menu selected
Acarix Acarix
  • Product

    Background

    • What is Coronary Artery Disease (CAD)?
    • Diagnosing CAD

    About the product

    • The CADScor® System
    • How does it work
  • Resources

    Testimonials

    • HCP stories
    • Patient stories

    References

    • Clinical Studies
    • Questionnaire
    • Downloads (US)
    • Downloads (EU)
    • Education

    Support

    • Training
    • FAQ
    • Reimbursement

    Physician Locator

    • Germany
  • Investors
    • Corporate Governance
    • General Meetings
    • Financial Reports and Calendar
    • The Acarix Share
    • Rights Issue/Warrant Program
    • Previous Rights Issue
    • Investor Presentations
  • Company

    Who we are

    • About Acarix
    • leadership
    • Join the team

    Get in touch

    • Contact us
    • Investigator Initiated Study
  • News
    • Press
    • Events
    • Social Media
Account
Search
Book a Demo
Acarix Acarix
Book a demo
Menu
author-avatar acarix
Corporate Information, IR, News, Other Corporate Information, Swedish
November 18, 2024
14 Jan 2020

Första patienterna utvärderas med CADScor®System i Storbritannien

Pressmeddelande Malmö, Sverige, 14 januari, 2020 Första patienterna utvärderas med CADScor®System i Storbritannien...
Continue reading
author-avatar acarix
Corporate Information, English, IR, News, Other Corporate Information
November 18, 2024
20 Dec 2019

Acarix AB: Redeye initiates coverage of Acarix

Redeye initiates coverage of Acarix. The company's significant potential hinges on its CADScor system's invention of coronary artery di...
Continue reading
author-avatar acarix
Corporate Information, English, IR, News, Other Corporate Information
November 18, 2024
16 Dec 2019

Acarix submits FDA application

Press release Malmö, Sweden 16 December, 2019 Acarix submits FDA application Acarix AB (publ) (ACARIX: FN Stockholm) today anno...
Continue reading
author-avatar acarix
Corporate Information, IR, News, Other Corporate Information, Swedish
November 18, 2024
16 Dec 2019

Acarix lämnar in FDA-ansökan

Pressmeddelande Malmö, Sverige, 16 december, 2019 Acarix lämnar in FDA-ansökan Acarix AB (publ) (ACARIX: FN Stockholm...
Continue reading
author-avatar acarix
English, Interim, IR, MAR, News, Q3, Regulatory, Report
November 18, 2024
14 Nov 2019

Acarix AB (publ) publishes Interim Report, January – September 2019

Malmö, November 14, 2019 Acarix finalized a rights issue to finance further market expansion In September we announced a rig...
Continue reading
author-avatar acarix
Interim, IR, MAR, News, Q3, Regulatory, Report, Swedish
November 18, 2024
14 Nov 2019

Acarix AB (publ) publicerar delårsrapport, januari – september 2019

Malmö den 14 november 2019 Acarix genomförde en företrädesemission för fortsatt marknadsexpansion Nylige...
Continue reading
author-avatar acarix
Corporate Action, English, IR, Issuance, Listing Regulation, News, Regulatory, Shares
November 18, 2024
30 Oct 2019

Acarix announce final outcome in rights issue

Press release Malmö, 30 October 2019Inside informationAcarix ABAcarix announce final outcome in rights issueAcarix AB ("Acarix" or...
Continue reading
author-avatar acarix
Corporate Action, IR, Issuance, Listing Regulation, News, Regulatory, Shares, Swedish
November 18, 2024
30 Oct 2019

Acarix offentliggör slutgiltigt utfall i företrädesemission

Pressmeddelande  Malmö, 30 oktober 2019InsiderinformationAcarix ABAcarix offentliggör slutgiltigt utfall i för...
Continue reading
author-avatar acarix
Corporate Action, IR, Issuance, Listing Regulation, News, Regulatory, Shares, Swedish
November 18, 2024
09 Oct 2019

Idag inleds teckningsperioden i Acarix företrädesemission

Pressmeddelande  Malmö, 9 oktober 2019Idag inleds teckningsperioden i Acarix företrädesemissionStyrelsen i Acarix A...
Continue reading
author-avatar acarix
Corporate Action, English, IR, Issuance, Listing Regulation, News, Regulatory, Shares
November 18, 2024
09 Oct 2019

The subscription period in Acarix’ rights issue commence today

Press releaseMalmö, 9 October 2019The subscription period in Acarix' rights issue commence todayThe board of directors of Acarix A...
Continue reading
author-avatar acarix
Corporate Action, IR, Listing Regulation, News, Prospectus, Regulatory, Swedish
November 18, 2024
30 Sep 2019

Acarix offentliggör EU-tillväxtprospekt i samband med företrädesemission om cirka 51,8 MSEK

Pressmeddelande Malmö, 30 september 2019Acarix offentliggör EU-tillväxtprospekt i samband med företrädese...
Continue reading
author-avatar acarix
Corporate Action, English, IR, Listing Regulation, News, Prospectus, Regulatory
November 18, 2024
30 Sep 2019

Acarix publish EU growth prospectus in connection with rights issue of up to approximately SEK 51.8 million

Press releaseMalmö, 30 September 2019Acarix publish EU growth prospectus in connection with rights issue of up to approximately SE...
Continue reading
  • «
  • ‹
  • 28
  • 29
  • 30
  • 31
  • 32
  • ›
  • »
Acarix AB
Jungmansgatan 12
211 19 Malmö
SE
[email protected]

Product

Background

  • What is Coronary Artery Disease (CAD)?
  • Diagnosing CAD

About the product

  • The CADScor® System
  • How does it work

Resources

Testimonials

  • HCP stories
  • Patient stories

Support

  • Training
  • FAQ

References

  • Clinical Studies
  • Downloads (US)
  • Downloads (EU)

Investors

  • Corporate Governance
  • General Meetings
  • Financial Reports and Calendar
  • The Acarix Share
  • Rights Issue
  • Investor Presentations

Company

Who we are

  • About Acarix
  • Management
  • Join the team

Get in touch

  • Contact us
  • LinkedIn
  • Twitter

News

  • Press
  • Events
  • Cookie policy
  • Privacy Policy: Clinical Studies
  • Privacy Policy
  • Cookie policy
  • Privacy Policy: Clinical Studies
  • Privacy Policy

Acarix, 2025. All rights reserved V5

  • Products
    • Background
    • What is Coronary Artery Disease
    • Diagnosing CAD
    • About the product
    • The Cadscor System
    • How Does it Work
  • Resources
    • Testimonial
    • HCP Stories
    • Patients Stories
    • References
    • Clinical Studies
    • Downloads (US)
    • Downloads (EU)
    • Support
    • Training
    • Faq
    • Reimbursement
    • Physician Locator
    • Germany
  • Investors
    • Corporate Governance
    • General Meetings
    • Financial Reports and Calendar
    • The Acarix Share
    • Right Issue
    • Previous Rights Issue
    • Investor Presentations
  • Company
    • Who we are
    • About Acarix
    • Leadership
    • Join The Team
    • Get in touch
    • Contact Us
    • Investigator Initiated Study
  • News
    • News
    • Press
    • Events
    • Socialmedia
Start typing to see products you are looking for.